论文部分内容阅读
目的 :探讨血浆肌钙蛋白I(ScTnI)对急性肺血栓栓塞预后的评估价值。方法 :分析我院近 4年确诊急性肺血栓栓塞并行ScTnI检查的患者共 3 3例 ,分为ScTnI <0 1ng/ml组 (n =2 0 )及ScTnI≥ 0 1ng/ml组 (n =13 ) ,分析ScTnI水平与转归的关系。结果 :ScTnI <0 1ng/ml组中大面积肺血栓栓塞 9例 ,次大面积 4例 ,非大面积 7例 ;合并低血压休克者 6例 ;治疗后 8例患者呼吸困难完全消失 ,11例呼吸困难基本消失 ;1例死亡。ScTnI≥ 0 1ng/ml组中大面积肺血栓栓塞 12例 ,次大面积 1例 ;合并低血压休克者 11例 ;治疗后 3例呼吸困难完全消失 ,3例呼吸困难基本消失 ,7例住院期间死亡。 2组间低血压休克发生率及病死率存在显著性差异 (P <0 0 1)。结论 :急性肺血栓栓塞ScTnI升高者预后差 ,住院期间低血压休克发生率及病死率显著升高。
Objective: To evaluate the value of plasma Troponin I (ScTnI) in predicting the prognosis of acute pulmonary thromboembolism. Methods: A total of 3 3 patients with acute pulmonary thromboembolism who underwent ScTnI examination in the past 4 years were divided into three groups: ScTnI <0 1ng / ml group (n = 20) and ScTnI≥0 1ng / ml group (n = 13 ), Analyze the relationship between the level of ScTnI and outcome. Results: There were 9 cases of large pulmonary thromboembolism in ScTnI <0 1ng / ml group, 4 cases of sub-large area, 7 cases of non-large area; 6 cases of shock with hypotension; 8 cases of dyspnea disappeared completely and 11 cases Dyspnea basically disappeared; 1 patient died. In the group of ScTnI≥0 1ng / ml, there were 12 cases of large pulmonary thromboembolism, 1 case of sub-large area; 11 cases of shock with hypotension; 3 cases of dyspnea disappeared completely, 3 cases of dyspnea disappeared, 7 cases were hospitalized death. There was a significant difference in the incidence and mortality of hypotensive shock between the two groups (P <0.01). Conclusion: The patients with acute pulmonary embolism who have elevated ScTnI have a poor prognosis and the incidence and mortality of hypotensive shock during hospitalization are significantly higher.